Biopharmaceutical innovation can cost billions and take over a decade to bear fruit. Salvation lies in swapping paper trails ...

Orphan drugs are therapeutics developed to address rare diseases typically defined by patient population thresholds that vary ...

The Massachusetts bioresearch centre expansion is part of AbbVie’s wider ploy to bolster its US operations amid Trump tariff ...

We caught up with the team behind the first ever mobile leukapheresis center to see what community-based care could look like ...

Artificial intelligence (AI) promises to transform the future of clinical research, but not every application adds value.

The US Government has shut down for the first time since 2018 after a majority of Democrat senators refused to back ...

Biogenetics company Klotho Neurosciences has announced plans to acquire certain assets from Turn Biotechnologies.

Star Therapeutics has completed a Series D funding round, raising $125m, aimed at supporting its pipeline progression.

As part of President Trump’s Most Favored Nation (MFN) policy, the company agreed to ensure that US patients are paying less ...

APG808 resulted in a rapid and durable decrease from baseline in FeNO and pSTAT6 measurements throughout the 12 weeks.

Changing trends in the biopharma sector may mean new risks for established players and opportunities for growth, says BIA ...

Oral liquid drugs play a vital role for patients who have difficulty swallowing tablets and for those requiring personalised ...